Weight Loss and Body Shape with Lipodystrophy in South Africa

Lipodystrophy is a group of disorders characterised by abnormal loss or redistribution of body fat — not from dieting, but from disease or medication. In South Africa, the most clinically significant form is HIV-associated lipodystrophy (also called antiretroviral therapy lipodystrophy or HAART-associated lipodystrophy syndrome — HALS), affecting a substantial proportion of people on long-term antiretroviral therapy (ART). South Africa has the world's largest HIV treatment programme — approximately 5.5 million people on ART by 2025 — making lipodystrophy a major public health nutrition issue in this country. Additionally, rare genetic forms (familial partial lipodystrophy and congenital generalised lipodystrophy) affect small numbers of South Africans but are severely metabolically disruptive. Lipodystrophy is not simply a cosmetic issue: it drives insulin resistance, hypertriglyceridaemia, liver disease (NAFLD/MASLD), and cardiovascular risk — all requiring targeted nutritional management.

Types of Lipodystrophy: South African Relevance

Type	Cause	Body Fat Pattern	SA Prevalence
HIV/ART Lipoatrophy	Older nucleoside reverse transcriptase inhibitors (NRTIs): stavudine (d4T), zidovudine (AZT)	Fat loss from face, limbs, buttocks; hollow cheeks, visible veins on arms	Common in patients on older regimens; less so on modern TDF/TAF-based regimens
HIV/ART Lipohypertrophy	Protease inhibitors (older generation), immune reconstitution, HIV itself	Central fat accumulation: visceral abdominal fat, dorsocervical fat pad ("buffalo hump"), breast enlargement	Common in patients on longer-term ART; increasingly recognised
Mixed lipodystrophy (HALS)	Combined peripheral fat loss + central fat gain	Thin limbs + protruding abdomen; dramatic body shape distortion	Most common pattern in SA patients on ART >5 years
Familial Partial Lipodystrophy (FPLD)	LMNA, PPARG, or PLIN1 gene mutations	Fat loss from limbs and trunk; excess fat accumulation in face and neck	Rare; underdiagnosed; often misdiagnosed as type 2 diabetes or PCOS in women
Congenital Generalised Lipodystrophy (CGL)	AGPAT2, BSCL2 gene mutations	Near-complete absence of body fat from birth; muscular appearance; severe metabolic disease	Very rare; presents in childhood; requires specialist centre management

The Metabolic Consequences of Lipodystrophy

Fat tissue is not merely storage — it is metabolically active endocrine tissue. When fat is lost from the periphery and redistributes to visceral stores (or is largely absent), the metabolic consequences are severe:

Severe insulin resistance — visceral adipose tissue secretes inflammatory cytokines (TNF-alpha, IL-6) that impair insulin signalling; leptin deficiency (especially in CGL) removes a key appetite and insulin satiety signal
Extreme hypertriglyceridaemia — triglycerides in lipodystrophy can reach 10–100 mmol/L (normal <1.7 mmol/L); risk of acute pancreatitis
Non-alcoholic fatty liver disease (NAFLD/MASLD) — fat displaced from peripheral stores floods the liver; hepatomegaly and liver dysfunction are common
Type 2 diabetes (or type 1-like in CGL) — extreme insulin resistance drives frank diabetes in most lipodystrophy patients
Dyslipidaemia — elevated LDL, low HDL, high triglycerides = accelerated cardiovascular disease
Polycystic ovary syndrome (PCOS)-like picture in women — androgen excess, menstrual irregularity, infertility

Pancreatitis risk: Triglycerides above 10 mmol/L carry significant acute pancreatitis risk. Above 20 mmol/L is a medical emergency requiring hospitalisation. If you have severe hypertriglyceridaemia, a very low fat diet (<15% of calories from fat) is not just helpful — it is urgent and potentially life-saving. This requires dietitian input immediately.

HIV/ART Lipodystrophy: Diet and Lifestyle Strategy

Step 1: Regimen Switch Discussion with Your HIV Clinician

The most effective intervention for ART-associated lipoatrophy is switching away from the causative drug. In South Africa, the public sector standard of care has largely shifted away from stavudine (d4T) and zidovudine (AZT) — which are most strongly associated with lipoatrophy — to tenofovir disoproxil fumarate (TDF) or tenofovir alafenamide (TAF)-based regimens. If you are still on an older regimen showing lipoatrophy, speak to your HIV clinician about regimen optimisation before focusing on diet. Diet alone cannot reverse ART-induced lipoatrophy.

Step 2: Metabolic Management Through Diet

Once the regimen is optimised (or while awaiting a switch), diet targets the metabolic consequences:

For High Triglycerides (Very Common in HALS)

Reduce refined carbohydrates drastically — sugar, white bread, fizzy drinks (Coke, Fanta), sweets, pap made from refined mealie meal — all raise triglycerides significantly; this is the highest-impact dietary change
Eliminate alcohol — alcohol is the most potent dietary driver of hypertriglyceridaemia; even one drink raises triglycerides measurably; abstinence is recommended in severe cases
Limit saturated fat — fatty cuts of meat, full-fat dairy, palm oil, coconut oil, droewors, fatty boerewors — replace with lean protein (skinless chicken, fresh fish, legumes)
Increase omega-3 fatty acids — fish (sardines, pilchards, mackerel, hake) 3–4 times/week; omega-3 supplementation (2–4 g EPA+DHA/day) significantly lowers triglycerides — discuss with your clinician; Biogen Omega-3 and Solgar are widely available in SA
Increase soluble fibre — oats, legumes (sugar beans, lentils, cowpeas), psyllium husk (available at Dis-Chem); soluble fibre binds lipids in the gut and lowers both cholesterol and triglycerides

Fibre upgrade: Replace refined pap with oat porridge at breakfast — one of the highest-impact single food changes for improving lipid profiles in South African HIV patients. Add a tablespoon of ground flaxseed for additional omega-3 and fibre benefit.

For Insulin Resistance and Central Fat

Low glycaemic index diet — coarse pap, oats, sweet potato, legumes, whole fruit (not juice) over refined starches and sugary foods
Mediterranean-pattern eating — olive oil, fish, vegetables, legumes, moderate whole grains; shown to improve insulin sensitivity and reduce visceral fat even without calorie restriction
Calorie deficit of 300–500 kcal/day — moderate restriction is effective for central fat; do not crash-diet; visceral fat is lost with modest, sustained deficit
Protein target: 1.2–1.5 g/kg/day — preserves lean muscle mass during weight loss; especially important in lipodystrophy where peripheral muscle is often already reduced
Meal timing — spreading food evenly across the day (3 meals + 2 snacks) improves insulin sensitivity and avoids large post-meal glucose spikes

For Fatty Liver (NAFLD/MASLD)

Weight loss of 5–10% is the most effective intervention for reversing NAFLD — even modest loss reduces liver fat significantly
Fructose restriction — fructose (in table sugar, high-fructose corn syrup, fruit juice, and sweet drinks) is uniquely liver-fattening; eliminate sugary drinks entirely; limit fruit juice to 125ml/day
Coffee — regular filter coffee (2–3 cups/day) is associated with reduced liver fibrosis in NAFLD; one of the few drinks with a protective effect; switch to decaffeinated if cardiac symptoms are a concern
Alcohol: zero tolerance — alcohol is hepatotoxic on top of NAFLD; no safe amount in fatty liver disease

Familial Partial Lipodystrophy (FPLD): Specific Dietary Approach

FPLD (most commonly Dunnigan type — LMNA gene mutation) has an extremely severe metabolic phenotype. Women with FPLD are frequently diagnosed in their 30s when diabetes and severe hypertriglyceridaemia become apparent — many are initially misdiagnosed with type 2 diabetes or PCOS.

Very low fat diet — the most critical dietary intervention; target 15–20% of total calories from fat to reduce circulating triglycerides; this requires a dietitian's help to achieve while maintaining nutrition
MCT oil as the primary fat source — medium-chain triglycerides (C8/C10) bypass lymphatic transport and do not raise chylomicrons; available at Dis-Chem; used as cooking oil replacement
Complete refined carbohydrate elimination — table sugar, white bread, rice, pap from refined mealie meal are all contraindicated in FPLD-associated hypertriglyceridaemia
Insulin or metreleptin therapy — most FPLD patients require insulin therapy for diabetes; metreleptin (recombinant leptin) is available on compassionate access in SA for CGL and some FPLD cases; diet must support these therapies
Fibrate medications (fenofibrate, gemfibrozil) — prescribed by specialists for triglyceride lowering; dietary fat restriction synergises with fibrate therapy

Exercise: The Most Underused Tool in Lipodystrophy

Exercise is particularly effective in lipodystrophy — improving insulin sensitivity, reducing visceral fat, and improving cardiovascular risk profile:

Exercise Type	Benefit	Recommendation
Aerobic exercise (walking, cycling, swimming)	Burns visceral fat; improves insulin sensitivity; lowers triglycerides	150 min/week minimum; 300 min/week for significant fat loss
Resistance training (weights, bodyweight)	Preserves and builds muscle mass; improves peripheral fat redistribution aesthetically; raises metabolic rate	2–3 sessions/week; particularly important for HALS patients with peripheral muscle wasting
HIIT (high-intensity intervals)	Very effective for visceral fat loss; time-efficient	Only if cardiac status cleared; not for patients with severe hypertriglyceridaemia until levels controlled

SA community gym access: Planet Fitness, Virgin Active, and Gym Company have branches across Gauteng, Western Cape, and KwaZulu-Natal with affordable membership tiers. Many community recreation centres also offer weight rooms at lower cost. Government health clinics sometimes have chronic disease exercise programmes.

Key Nutrients to Monitor and Supplement

Nutrient	Why It Matters in Lipodystrophy	SA Sources / Options
Omega-3 (EPA + DHA)	Lowers triglycerides; anti-inflammatory; reduces cardiovascular risk	Pilchards, sardines, mackerel daily; supplement 2–4 g EPA+DHA/day if TGs >5 mmol/L
Vitamin D3	HIV infection and some ARVs impair vitamin D metabolism; deficiency worsens insulin resistance	1 000–2 000 IU/day; check serum 25-OH-D at annual bloods
Magnesium	Low in insulin-resistant states; required for glucose metabolism and cardiac health	Magnesium glycinate 200–300 mg/day; dark leafy vegetables, pumpkin seeds
Psyllium husk / soluble fibre	Lowers LDL and triglycerides; improves glucose control	Metamucil or generic psyllium at Dis-Chem; add to water or maas
Coenzyme Q10	Some NRTIs deplete mitochondrial CoQ10; may assist with fatigue	100–200 mg/day; Solgar/Natroceutics brands available SA

Monitoring: Annual Metabolic Checks for Lipodystrophy

Test	Why	Target
Fasting triglycerides	Pancreatitis risk; diet response tracking	<1.7 mmol/L; urgent review if >10 mmol/L
Fasting glucose / HbA1c	Insulin resistance / diabetes monitoring	Fasting glucose <6.1 mmol/L; HbA1c <7% if diabetic
Liver function tests (ALT/AST)	NAFLD/MASLD monitoring	Within normal range; rising ALT signals worsening fatty liver
Fasting lipid profile (TC, LDL, HDL, TG)	Cardiovascular risk management	LDL <2.5 mmol/L (or <1.8 in high-risk); HDL >1.0 mmol/L (men), >1.2 (women)
Blood pressure	Visceral adiposity and insulin resistance drive hypertension	<130/80 mmHg
Waist circumference	Tracks visceral fat response to diet and exercise	<94 cm men; <80 cm women (IDF criteria)

SA-Specific Resources

SA HIV Clinicians Society — hivssa.com — HIV management guidelines including lipid management in ART
National Department of Health (NDOH) ART Programme — public sector ART sites at all district hospitals and most CHCs
SEMDSA — endocrinology referral for metabolic complications; semdsa.org.za
ADSA — registered dietitians with HIV and metabolic experience; adsa.org.za
Lipodystrophy United (lipodystrophyunited.org) — international patient advocacy; includes genetic lipodystrophy forms
Rare Diseases South Africa — support for familial forms; rarediseases.org.za
Anova Health Institute, Wits Reproductive Health & HIV Institute (Wits RHI) — SA-based HIV research centres offering metabolic complication management

Managing lipodystrophy — HIV-associated or genetic?
A dietitian with experience in HIV or metabolic disorders can create a personalised plan for your triglyceride, glucose, and body composition goals. This article is educational only.
Find an SA Dietitian Near You →

Key Takeaways

HIV/ART lipodystrophy (HALS) is the most common lipodystrophy in South Africa — affecting millions of people on long-term ART; regimen switch (away from stavudine/zidovudine) is the first intervention
Hypertriglyceridaemia is the most dangerous metabolic complication — sugar and alcohol elimination is the highest-impact dietary change; triglycerides above 10 mmol/L require urgent medical review
Omega-3 fatty acids (from pilchards, sardines, mackerel or supplements) are the most evidence-based dietary tool for lowering triglycerides in lipodystrophy
Mediterranean-pattern diet with low refined carbohydrates, soluble fibre, and adequate protein addresses insulin resistance, visceral fat, and fatty liver simultaneously
Exercise — both aerobic and resistance — is highly effective for visceral fat reduction and insulin sensitivity improvement
Familial lipodystrophy forms require specialist metabolic unit care; very low fat diets (15–20% fat) and MCT oil are pillars of nutritional management
Annual metabolic screening (triglycerides, glucose, liver function, lipid profile, blood pressure) is essential for all patients with lipodystrophy

Disclaimer: This article is for educational purposes only. Lipodystrophy management — whether HIV-associated or genetic — requires specialist medical and dietetic care. Do not adjust ART regimens without consulting your HIV clinician. All dietary changes should be supervised. Information reviewed 2026.

Sources: SA HIV Clinicians Society Guidelines 2024; SEMDSA; Southern African Journal of HIV Medicine; ADSA; Lipodystrophy United; Orphanet; South African Medicines Formulary (SAMF) 17th ed.; WHO Consolidated HIV Guidelines.